REGISTERED
on 13 Jun 2023
Last Applicant/ Owned by
1025 Vermont Avenue, N.W.
Washington
DC
20005
Serial Number
97080134 filed on 18th Oct 2021
Registration Number
7081938 registered on 13th Jun 2023
Correspondent Address
David M. Abrahams
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
LFB LEAD FROM BEHIND
Promoting public awareness of colon cancer and the importance of screening for early detection of colon cancer; promoting public awareness of colon cancer and the importance of screening for early detection of colon cancer through marketing, social media, communications and grassroots campaigns
Classification Information
Class [035]
Advertising, Business & Retail Services
Promoting public awareness of colon cancer and the importance of screening for early detection of colon cancer; promoting public awareness of colon cancer and the importance of screening for early detection of colon cancer through marketing, social media, communications and grassroots campaigns
First Use Date in General
13th Sep 2022
First Use Date in Commerce
13th Sep 2022
Specimens
Mark Details
Serial Number
No 97080134
Mark Type
No Service Mark
Attorney Docket Number
No CCA
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Design Code(s)
02.11.25 -
Other parts of the human body
27.03.02 -
Representations of human beings or parts of human beings forming letters or numerals, including punctuation
Legal History
| Status Date | Action Taken |
|---|---|
| 13th Jun 2023 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| 13th Jun 2023 | REGISTERED-PRINCIPAL REGISTER |
| 11th May 2023 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| 10th May 2023 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| 04th May 2023 | STATEMENT OF USE PROCESSING COMPLETE |
| 03rd May 2023 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 14th Apr 2023 | USE AMENDMENT FILED |
| 14th Apr 2023 | TEAS STATEMENT OF USE RECEIVED |
| 25th Oct 2022 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| 30th Aug 2022 | PUBLISHED FOR OPPOSITION |